HomeQuestion

How long do you trial lifestyle therapy before initiating pharmacologic treatment in a patient with BMI 30–35 without diabetes?

Join the Discussion

Discuss the cases and questions guidelines don't cover.

Related Questions

How do you decide between bariatric surgery and a GLP-1 receptor agonist for patients with metabolic dysfunction-associated steatotic liver disease who have not met weight loss goals after six months of lifestyle interventions?

Would you consider changing a non-diabetic patient with obesity and a history of CAD who is on semaglutide to tirzepatide if they have not achieved their weight loss goals?

Should orlistat be avoided in patients with a history of kidney stones?

In patients with iron deficiency due to history of gastric bypass or IBD, would you consider oral iron therapy if the iron deficiency anemia is mild?

Can procalcitonin be used as a marker for endothelial dysfunction emanating from chronic inflammation of obesity?

Evidence Meets Expertise

For Physicians

Mednet AI
Community

Company

About
Careers
Publications
Blog

Support

FAQs
Code of Conduct
AI Community Guidelines
Contact Us
Programs

Legal

Privacy Policy
Terms of Service

© 2026 Mednet Inc. All rights reserved.